507 related articles for article (PubMed ID: 34215150)
41. Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis.
Rovaris M; Bozzali M; Santuccio G; Iannucci G; Sormani MP; Colombo B; Comi G; Filippi M
J Neurol Neurosurg Psychiatry; 2000 Dec; 69(6):723-7. PubMed ID: 11080222
[TBL] [Abstract][Full Text] [Related]
42. Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosis.
Bieniek M; Altmann DR; Davies GR; Ingle GT; Rashid W; Sastre-Garriga J; Thompson AJ; Miller DH
J Neurol Neurosurg Psychiatry; 2006 Sep; 77(9):1036-9. PubMed ID: 16793860
[TBL] [Abstract][Full Text] [Related]
43. Longitudinal cortical thinning progression differs across multiple sclerosis phenotypes and is clinically relevant: A multicentre study.
Hidalgo de la Cruz M; Valsasina P; Gobbi C; Gallo A; Zecca C; Bisecco A; Tedeschi G; Filippi M; Rocca MA
Mult Scler; 2021 May; 27(6):827-840. PubMed ID: 32662748
[TBL] [Abstract][Full Text] [Related]
44. Relevance of early cervical cord volume loss in the disease evolution of clinically isolated syndrome and early multiple sclerosis: a 2-year follow-up study.
Hagström IT; Schneider R; Bellenberg B; Salmen A; Weiler F; Köster O; Gold R; Lukas C
J Neurol; 2017 Jul; 264(7):1402-1412. PubMed ID: 28600596
[TBL] [Abstract][Full Text] [Related]
45. Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis.
Barro C; Benkert P; Disanto G; Tsagkas C; Amann M; Naegelin Y; Leppert D; Gobbi C; Granziera C; Yaldizli Ö; Michalak Z; Wuerfel J; Kappos L; Parmar K; Kuhle J
Brain; 2018 Aug; 141(8):2382-2391. PubMed ID: 29860296
[TBL] [Abstract][Full Text] [Related]
46. Cervical cord myelin abnormality is associated with clinical disability in multiple sclerosis.
Lee LE; Vavasour IM; Dvorak A; Liu H; Abel S; Johnson P; Ristow S; Au S; Laule C; Tam R; Li DK; Cross H; Ackermans N; Schabas AJ; Chan J; Sayao AL; Devonshire V; Carruthers R; Traboulsee A; Kolind S
Mult Scler; 2021 Dec; 27(14):2191-2198. PubMed ID: 33749378
[TBL] [Abstract][Full Text] [Related]
47. The impact of cervical spinal cord atrophy on quality of life in multiple sclerosis.
Zurawski J; Glanz BI; Healy BC; Tauhid S; Khalid F; Chitnis T; Weiner HL; Bakshi R
J Neurol Sci; 2019 Aug; 403():38-43. PubMed ID: 31207364
[TBL] [Abstract][Full Text] [Related]
48. Gray matter atrophy in multiple sclerosis: a longitudinal study.
Fisher E; Lee JC; Nakamura K; Rudick RA
Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
[TBL] [Abstract][Full Text] [Related]
49. The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis.
Cohen AB; Neema M; Arora A; Dell'oglio E; Benedict RH; Tauhid S; Goldberg-Zimring D; Chavarro-Nieto C; Ceccarelli A; Klein JP; Stankiewicz JM; Houtchens MK; Buckle GJ; Alsop DC; Guttmann CR; Bakshi R
J Neuroimaging; 2012 Apr; 22(2):122-8. PubMed ID: 21447024
[TBL] [Abstract][Full Text] [Related]
50. Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis.
Kearney H; Schneider T; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Ciccarelli O; Miller DH
J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):608-14. PubMed ID: 25097217
[TBL] [Abstract][Full Text] [Related]
51. Relaxometry and brain myelin quantification with synthetic MRI in MS subtypes and their associations with spinal cord atrophy.
Ladopoulos T; Matusche B; Bellenberg B; Heuser F; Gold R; Lukas C; Schneider R
Neuroimage Clin; 2022; 36():103166. PubMed ID: 36081258
[TBL] [Abstract][Full Text] [Related]
52. Multiple sclerosis by phenotype in Germany.
Engelhard J; Oleske DM; Schmitting S; Wells KE; Talapala S; Barbato LM
Mult Scler Relat Disord; 2022 Jan; 57():103326. PubMed ID: 35158442
[TBL] [Abstract][Full Text] [Related]
53. Focal and diffuse cervical spinal cord damage in patients with early relapsing-remitting MS: A multicentre magnetisation transfer ratio study.
Combès B; Kerbrat A; Ferré JC; Callot V; Maranzano J; Badji A; Le Page E; Labauge P; Ayrignac X; Carra Dallière C; de Champfleur NM; Pelletier J; Maarouf A; de Seze J; Collongues N; Brassat D; Durand-Dubief F; Barillot C; Bannier E; Edan G
Mult Scler; 2019 Jul; 25(8):1113-1123. PubMed ID: 29909771
[TBL] [Abstract][Full Text] [Related]
54. Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study.
Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Barkhof F; Schoonheim MM; Strijbis EM; Vrenken H; Gallo A; Bisecco A; Ciccarelli O; Yiannakas M; Rovira A; Sastre-Garriga J; Palace J; Matthews L; Gass A; Eisele P; Lukas C; Bellenberg B; Margoni M; Preziosa P; Filippi M;
J Neurol Neurosurg Psychiatry; 2023 Jan; 94(1):10-18. PubMed ID: 36171105
[TBL] [Abstract][Full Text] [Related]
55. Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: A multiparametric MRI study.
Hidalgo de la Cruz M; Valsasina P; Meani A; Gallo A; Gobbi C; Bisecco A; Tedeschi G; Zecca C; Rocca MA; Filippi M
Mult Scler; 2022 Mar; 28(3):406-417. PubMed ID: 34124963
[TBL] [Abstract][Full Text] [Related]
56. Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
Abdel-Aziz K; Schneider T; Solanky BS; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Peters AL; Day BL; Thompson AJ; Ciccarelli O
Brain; 2015 Jun; 138(Pt 6):1568-82. PubMed ID: 25863355
[TBL] [Abstract][Full Text] [Related]
57. Spinal cord volume loss: A marker of disease progression in multiple sclerosis.
Tsagkas C; Magon S; Gaetano L; Pezold S; Naegelin Y; Amann M; Stippich C; Cattin P; Wuerfel J; Bieri O; Sprenger T; Kappos L; Parmar K
Neurology; 2018 Jul; 91(4):e349-e358. PubMed ID: 29950437
[TBL] [Abstract][Full Text] [Related]
58. Cross-sectional and longitudinal assessment of the upper cervical spinal cord in motor neuron disease.
van der Burgh HK; Westeneng HJ; Meier JM; van Es MA; Veldink JH; Hendrikse J; van den Heuvel MP; van den Berg LH
Neuroimage Clin; 2019; 24():101984. PubMed ID: 31499409
[TBL] [Abstract][Full Text] [Related]
59. Prognostic value of single-subject grey matter networks in early multiple sclerosis.
Fleischer V; Gonzalez-Escamilla G; Pareto D; Rovira A; Sastre-Garriga J; Sowa P; Høgestøl EA; Harbo HF; Bellenberg B; Lukas C; Ruggieri S; Gasperini C; Uher T; Vaneckova M; Bittner S; Othman AE; Collorone S; Toosy AT; Meuth SG; Zipp F; Barkhof F; Ciccarelli O; Groppa S
Brain; 2024 Jan; 147(1):135-146. PubMed ID: 37642541
[TBL] [Abstract][Full Text] [Related]
60. Regional white matter atrophy--based classification of multiple sclerosis in cross-sectional and longitudinal data.
Sampat MP; Berger AM; Healy BC; Hildenbrand P; Vass J; Meier DS; Chitnis T; Weiner HL; Bakshi R; Guttmann CR
AJNR Am J Neuroradiol; 2009 Oct; 30(9):1731-9. PubMed ID: 19696139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
